The tuition-free program trained unemployed and under-employed Maryland residents for careers in biotechnology and biomedical ...
In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...
A series of biotech acquisitions transpired in under 9 months — totaling more than $3.5 billion. The drugs behind them target ...
Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.
Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over ...
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...
Roivant Sciences (NASDAQ: ROIV) certainly seems like a rising star. The biotech stock has more than tripled over the past year, soaring to $35 per share and a market cap of $25 billion. Roivant is a ...
VERAXA Biotech (NASDAQ: VRXA) provided a corporate and pipeline update highlighting progress during the first half of 2026, ...
Verified Investing on MSN
My trading game plan revealed - 07/06/2026: S&P 500 line in the sand, chip sell-off, biotech rotation and yen carry risk
Gareth Soloway's technical market breakdown: S&P 500 trend-line test, semiconductor unwind, AI-to-biotech rotation, USD/JPY ...
Novartis has acquired UK biotech Myricx for up to $1.5bn as global drugmakers invest inpromising biotech firms ahead expected ...
11h
A drug already in human trials could reverse tooth loss by 2030, a condition that affects millions
Japanese biotech drug aims to reverse tooth loss by regrowing teeth. Here's how TRG-035 works, where trials stand and when it ...
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results